Lumakras
My Prescription
Payment
Select pharmacy
$23,575.80
Print or send this coupon to your phone
AlbertsonsPowered byAbout Lumakras
Drug Details
Lumakras (sotorasib) is prescribed for adults with metastatic non-small cell lung cancer (NSCLC) that exhibits a KRAS G12C mutation, particularly after other treatments have failed. This oral medication is taken once daily and works by inhibiting the KRAS G12C protein, which is responsible for promoting the uncontrolled growth of cancer cells. By targeting this specific mutation, Lumakras effectively helps to prevent tumor growth. Note that while Lumakras offers a convenient treatment option, it can lead to common side effects like stomach upset and fatigue. Always consult with your healthcare provider for advice tailored to your medical needs before starting any new medication.
Price history for Lumakras
120 Tablets, 240MG
Average retail price for Lumakras
Average SaveHealth price for Lumakras
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Lumakras dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 120MG | 240 Tablets | $23,575.80 | $98.23 |
| 240MG | 120 Tablets | $23,575.80 | $196.47 |
| 320MG | 90 Tablets | $23,575.80 | $261.95 |
Lumakras FAQs
The survival rate for Lumakras (sotorasib) can vary depending on several factors, including the specific type and stage of cancer being treated, as well as individual patient characteristics. Lumakras is primarily used for treating non-small cell lung cancer (NSCLC) with a specific KRAS G12C mutation. Clinical trials have shown that Lumakras can lead to a significant reduction in tumor size and progression-free survival in some patients. However, exact survival rates can differ, and it is important for patients to discuss their individual prognosis and treatment outcomes with their healthcare provider.
The cost of Lumakras can vary depending on factors such as insurance coverage, pharmacy, and location. On average, the monthly cost without insurance can be several thousand dollars. It is recommended to check with a specific pharmacy or insurance provider for the most accurate and up-to-date pricing information.
Lumakras (sotorasib) is not classified as a traditional chemotherapy drug. It is a targeted therapy used to treat certain types of non-small cell lung cancer (NSCLC) with a specific genetic mutation known as KRAS G12C. Targeted therapies like Lumakras work by specifically targeting cancer cells with this mutation, which can lead to fewer side effects compared to traditional chemotherapy.
Lumakras is used for the treatment of adults with non-small cell lung cancer (NSCLC) that has a specific mutation in the KRAS G12C gene. It is typically prescribed for patients whose cancer has progressed after receiving at least one prior systemic therapy.
Yes, sotorasib can be considered expensive. The cost of this medication can vary depending on factors such as insurance coverage, location, and healthcare provider. Patients are encouraged to discuss the cost and potential financial assistance options with their healthcare provider or pharmacist.